Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology - 1 Jan 2000

Esmat G, El Akel Wafaa, Metwally M, Soliman A, Doss W, Hamid M Abdel, Kamal M, Zalata K, Khattab H, El-Kassas M, Esmat M, Hasan A, El-Raziky M

Abstract excerpt

INTRODUCTION: Hepatic steatosis is common in patients with chronic hepatitis C virus (HCV) infection, and its occurrence may be related to both host and viral factors. Relationship between improvement in steatosis and response to anti-viral treatment remains unclear. This study assessed the facto...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Body Mass Index
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Liver

Share to Hepatitis C, Chronic

Share to Interferons

Share to Ribavirin

Share to Weight Loss

Source

Identifiers

PMID: 19696987
DOI: 10.1007/s12664-009-0016-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19696987-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.PMID 19696987Read ↗

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.Semantic proximity Read ↗

Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.Semantic proximity Read ↗

Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.Semantic proximity Read ↗

The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.Semantic proximity Read ↗

Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.Semantic proximity Read ↗

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.Semantic proximity Read ↗

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Semantic proximity Read ↗

Steatosis in chronic hepatitis C: why does it really matter?Semantic proximity Read ↗

Hepatitis C and steatosis.Semantic proximity Read ↗

Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C.Semantic proximity Read ↗

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.Semantic proximity Read ↗

Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.